Tyra Biosciences, Inc. filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-04-17. Between them they name 2 people. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: Habib J. Dable, Director
On April 16, 2026, upon the recommendation of the Nominating and Corporate Governance Committee of the board of directors (the Board) of Tyra Biosciences, Inc. (the Company), and pursuant to the amended and restated bylaws of the Company, the Board approved an increase in the number of authorized directors from nine to ten and appointed Habib J. Dable to the Board as a Class II director with an initial term expiring at the Company's 2026 annual meeting of stockholders.
Appointed: Julia Rueb, Chief Financial Officer, effective 2026-04-01
On April 1, 2026, the Board of Directors of Tyra Biosciences, Inc. (the Company) designated Julia Rueb, Vice President, Finance of the Company, as the Company's principal accounting officer, succeeding Alan Fuhrman, the Company's Chief Financial Officer, in that role, each effective as of April 1, 2026.
Find people with the same kind of experience as the Director at Tyra Biosciences, Inc., with the record behind each one.
Find candidates like Director at Tyra Biosciences, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Tyra Biosciences, Inc. is in the news or changes leadership.
Get an alert when Tyra Biosciences, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Tyra Biosciences, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.